Skip to content

Short-term Clinical Performance of Multifocal Soft Contact Lens

A Clinical Study of Short-term Clinical Performance of Multifocal Soft Contact Lens

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05273606
Enrollment
40
Registered
2022-03-10
Start date
2022-07-16
Completion date
2022-12-16
Last updated
2022-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

The study is aimed to observe the short-term clinical performance of MiSight™ multifocal soft contact lens compared with Proclear™ 1day, including objective examination, subjective acceptability of wearers, and doctors' evaluation of the clinical manifestations of lenses.

Detailed description

Compared with Proclear™ 1day, observe the short-term clinical performance of MiSight™ multifocal soft contact lens including objective examination, subjective acceptability of wearers, and doctors' evaluation of the clinical manifestations of lenses in 1 month.

Interventions

DEVICEMiSight mutifocal soft contact lens

Subjects will wear MiSight™ multifocal soft contact lenses for 1 month.

DEVICEProclear 1 Day soft contact lens

Proclear™ 1 Day soft contact lens will be worn for baseline evaluation.

Sponsors

Zhongshan Ophthalmic Center, Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* • Prior to being considered eligible to participate in this study, each subject MUST: 1. Be between 8 and 12 years of age inclusive at the baseline examination. 2. Have: 1. read the Informed Assent, 2. been given an explanation of the Informed Assent, 3. indicated an understanding of the Informed Assent and 4. signed the Informed Assent Form. 3. Have their parent or legal guardian: 1. read the Informed Consent, 2. been given an explanation of the Informed Consent, 3. indicated an understanding of the Informed Consent and 4. signed the Informed Consent Form. 4. Along with their parent or guardian, be capable of comprehending the nature of the study and be willing and able to adhere to the instructions set forth in this protocol. 5. Along with their parent or guardian, agree to maintain the visit schedule and be able to keep all appointments as specified in the study protocol for the duration of the study. 6. Agree to wear the assigned contact lenses for the duration of the 1-month study and to inform the study investigator if this schedule is interrupted. (Wearing time may be modified by the study staff for health reasons.) 7. Meet the following refractive criteria determined by cycloplegic autorefraction at baseline: 1. Spherical refractive error: between -0.75 and -4.00 D inclusive, 2. Astigmatism: ≤-0.75 D, 3. Anisometropia: ≤1.50D, 8. Best-corrected visual acuity :≥0.8.

Exclusion criteria

* • Subjects may not be considered eligible if ANY of the following apply: 1. Subject has regular use of ocular medications. 2. Any systemic disease which is not suggested to wear contact lens or current use of systemic medications which may significantly affect contact lens wear, visual function, or refractive state. 3. A history of ocular trauma or ocular surgery in the last 8 weeks. 4. Subject has worn rigid gas permeable contact lenses in the last 6 weeks, including orthokeratology lenses. 5. Abnormal secretion or excretion of tear fluid, infection of the tear ducts, or other recurrent ocular infections. 6. A known allergy to fluorescein, benoxinate, proparacaine, or tropicamide. 7. Keratoconus or an irregular cornea. 8. Subjects who have been in a special environment such as dryness, serious dust, or volatile chemicals for a long time affect the wear of contact lenses. 9. Strabismus, amblyopia patients, only one eye meets the admission conditions. 10. Subjects have received any myopia control treatment. 11. Subject is currently an active participant in another clinical study.

Design outcomes

Primary

MeasureTime frame
Change in the contrast sensitivity visual function (CSF) relative to baseline at 1 monthProclear baseline;VMisight baseline; 1 week; 1month

Secondary

MeasureTime frameDescription
Patients' subjective acceptability to multifocal soft contact lensProclear baseline; Misight baseline; 1 week; 1monthThe patients will be asked to complete questionnaires at each visit regarding vision, lens comfort, the difficulty of lens insert and removal, etc. of the multifocal contact lens.
Doctors' clinical evaluation to multifocal soft contact lensProclear baseline; Misight baseline; 1 week; 1monthThe doctors will be asked to complete questionnaires regarding the difficulty of fitting procedure and general impression of the multifocal contact lens.
Change in the contact lens corrected visual acuity relative to baselineProclear baseline;Misight baseline;1 week;1monthPatients will wear contact lens when they are tested

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026